Key Metrics
CiteScore 

3.9
Impact Factor 

< 5
SJR 

Q2Microbiology (medical)

SNIP 

0.71
Recommended pre-submission checks
Powered by 

New Microbiologica Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | EDIZIONI INT SRL |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in New Microbiologica
Primary Cutaneous Cryptococcosis Mimicking Vasculitis in a Patient with Rheumatoid Arthritis.
- 1 Dec 2025
- The new microbiologica
Rhodococcus equi in Advanced Antiretroviral Therapy-Naïve HIV-Positive Patients: Differential Diagnosis and Clinical Findings.
- 1 Dec 2025
- The new microbiologica
A Rare Case of Splenic Infarction Due to Brucellosis.
- 1 Dec 2025
- The new microbiologica
Rare Case of Campylobacter jejuni Bacteremia in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Comprehensive Evaluation of Clinical Management, Pathophysiology, and Public Health Implications.
- 1 Dec 2025
- The new microbiologica
In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.
- 1 Dec 2025
- The new microbiologica
In vitro activity of Cefepime/Enmetazobactam and Cefepime/Zidebactam against OXA-48-producing Klebsiella pneumoniae clinical strains.
- 1 Dec 2025
- The new microbiologica
Primary Cutaneous Cryptococcosis Mimicking Vasculitis in a Patient with Rheumatoid Arthritis.
- 1 Dec 2025
- The new microbiologica
Rhodococcus equi in Advanced Antiretroviral Therapy-Naïve HIV-Positive Patients: Differential Diagnosis and Clinical Findings.
- 1 Dec 2025
- The new microbiologica
A Rare Case of Splenic Infarction Due to Brucellosis.
- 1 Dec 2025
- The new microbiologica
Rare Case of Campylobacter jejuni Bacteremia in a Pediatric Patient with Acute Lymphoblastic Leukemia: A Comprehensive Evaluation of Clinical Management, Pathophysiology, and Public Health Implications.
- 1 Dec 2025
- The new microbiologica
In vitro Control of RNA Virus Infections by M1-Polarized Human Monocyte-Derived Macrophages.
- 1 Dec 2025
- The new microbiologica
In vitro activity of Cefepime/Enmetazobactam and Cefepime/Zidebactam against OXA-48-producing Klebsiella pneumoniae clinical strains.
- 1 Dec 2025
- The new microbiologica